Literature DB >> 2076725

Lack of effect of short-term passive smoking on the metabolic disposition of theophylline.

D T Casto1, B M Schnapf, M A Clotz.   

Abstract

To test the hypothesis that involuntary smoking can result in increased drug metabolism, five nonsmoking healthy male volunteers (21-36 y old) were enrolled in a study of single-dose theophylline pharmacokinetics before and after intense environmental tobacco smoke (ETS) exposure. Exposure was provided by spending 3 h/day for five consecutive days in a small room with a smoking apparatus that burned four cigarettes simultaneously, at a rate of 20 cigarettes/h. Measurement of urine continine concentration demonstrated that significant absorption from ETS occurred in all subjects. However, pre- and post-exposure pharmacokinetic parameters for theophylline did not differ significantly: Vz = 0.438 vs 0.440 l.kg-1; t1/2 = 9.19 vs 9.69 h; CL = 34.4 vs 32.6 (ml.kg-1.h-1), respectively. Similarly, 24-hr urinary excretion of theophylline and its metabolites was unchanged by ETS exposure. We conclude that intense short-term passive smoking does not affect theophylline disposition. The possibility of chronic ETS exposure causing alterations in drug metabolism cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076725     DOI: 10.1007/BF00315418

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

2.  Influence of turnover rates on the responses of enzymes to cortisone.

Authors:  C M Berlin; R T Schimke
Journal:  Mol Pharmacol       Date:  1965-09       Impact factor: 4.436

3.  Influence of tobacco abstinence on the disposition kinetics and effects of nicotine.

Authors:  B L Lee; N L Benowitz; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1987-04       Impact factor: 6.875

4.  Urinary cotinine as marker of breathing other people's tobacco smoke.

Authors:  N J Wald; J Boreham; A Bailey; C Ritchie; J E Haddow; G Knight
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

5.  Concurrent measurement of theophylline and caffeine in neonates by an interference-free liquid-chromatographic method.

Authors:  C N Ou; V L Frawley
Journal:  Clin Chem       Date:  1983-11       Impact factor: 8.327

6.  A simple machine for smoke analytical studies and total particulate matter collection for biological studies.

Authors:  R B Griffith
Journal:  Toxicology       Date:  1984-10       Impact factor: 4.221

Review 7.  Smoking and drug metabolism.

Authors:  G W Dawson; R E Vestal
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

8.  A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma.

Authors:  M Hariharan; T VanNoord; J F Greden
Journal:  Clin Chem       Date:  1988-04       Impact factor: 8.327

Review 9.  Influence of cigarette smoking on drug metabolism in man.

Authors:  W J Jusko
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

10.  Effects of passive smoking on theophylline clearance.

Authors:  S K Matsunga; P M Plezia; M D Karol; M D Katz; A E Camilli; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  1989-10       Impact factor: 6.875

View more
  3 in total

1.  Interaction of smoking, uptake of polycyclic aromatic hydrocarbons, and cytochrome P450IA2 activity among foundry workers.

Authors:  D Sherson; T Sigsgaard; E Overgaard; S Loft; H E Poulsen; F J Jongeneelen
Journal:  Br J Ind Med       Date:  1992-03

Review 2.  Impact of smoking on asthma therapy: a critical review of clinical evidence.

Authors:  Eric Livingston; Neil C Thomson; George W Chalmers
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.